2-(2-aryl-2-oxoalkylidene) analogs of-3,5-pyridinedicarboxylic a

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

514226, 514233, 514236, 514248, 514249, 514252, 514256, 514259, 514300, 514307, 514314, 514332, 514333, 514337, 514338, 514339, 514340, 514341, 514342, 514343, 514344, 514352, 514355, 514356, 514312, 544 49, 544 50, 544 52, 544 54, 544 586, 544 96, 544 98, 544235, 544238, 544284, 544333, 544353, 544405, 546121, 546122, 546145, 546146, 546147, 546168, 546170, 546256, 546262, 546263, 546269, 546270, 546271, 546273, 546274, 546275, 546278, 546279, 546280, 546281, 546283, 546284, 546286, 546310, 546315, 546321,

Patent

active

047328983

ABSTRACT:
The present invention are 2-(2-aryl-2-oxo-alkylidene) analogs of 1,2,3,4-tetrahydropyridine-3,5-pyridinecarboxylic acids and particularly esters thereof having valuable calcium antagonist and positive inotropic activity useful in the treatment of cardiovascular disorders, pharmaceutical compositions and methods of use therefor.

REFERENCES:
patent: 4146627 (1979-03-01), Wehinger et al.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

2-(2-aryl-2-oxoalkylidene) analogs of-3,5-pyridinedicarboxylic a does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 2-(2-aryl-2-oxoalkylidene) analogs of-3,5-pyridinedicarboxylic a, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2-(2-aryl-2-oxoalkylidene) analogs of-3,5-pyridinedicarboxylic a will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-442251

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.